Cardiovascular Business asked healthcare administrators for their favorite book recommendations. Here are a few of their responses.

It’s becoming evident that the Stark law is frustrating the move from volume to value. Experts expect changes that could allow health systems and practices to deploy better coordinated, team-based care and advanced alternative payment models.

REDWOOD CITY, CA — November 15, 2018 — Avinger, Inc. (AVGR), a commercial-stage medical device company that designs and develops the first-ever image-guided, catheter-based system that diagnoses and treats patients with peripheral artery disease (PAD), today announced the successful treatment of the first nine patients with Pantheris SV (Small Vessel) at two separate hospitals in Germany.

An observational study of nearly 35,000 Scandinavian patients with type 2 diabetes (T2D) has found sodium-glucose cotransporter 2 (SGLT2) inhibitors, a class of prescription drugs approved by the FDA to lower blood sugar in adults with T2D, may almost double patients’ risks of lower limb amputation and diabetic ketoacidosis compared to glucagon-like peptide 1 (GLP1) receptor agonists.

The shortage of Molybdenum-99 (Mo-99), which is used to create the crucial nuclear imaging radioisotope Technetium-99m, is expected to improve in the coming weeks.

Heart patients with symptoms of peripheral artery disease (PAD) continue to see low rates of prescriptions for antiplatelets, statins and ACE inhibitors, despite those drugs’ potential to prevent against major events like stroke, according to research published Nov. 15 in Stroke.

A machine learning-based risk calculator developed to assess an individual’s long-term risk for atherosclerotic cardiovascular disease (ASCVD) identified 13 percent more high-risk patients and recommended unnecessary statin therapy 25 percent less often than standard risk assessment tools in initial tests, researchers reported in the Journal of the American Heart Association.

A new study published in Circulation emphasized the importance of prompt arterial switch operations (ASOs) for infants with transposition of the great arteries, as neonates more than 6 days old were 90 percent more likely to die in the perioperative period.

Violence, an ever-growing presence in our global communities, isn’t just a social issue, according to research presented at the American Heart Association’s annual Scientific Sessions in Chicago Nov. 12. It’s a public health one, too, and it can have serious consequences for our heart health.

The FDA plans to take aggressive steps toward limiting youth access to tobacco products and banning the sale of flavored nicotine, the organization’s commissioner, Scott Gottlieb, MD, has announced in a statement.